MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
36.42
+0.08
+0.22%
After Hours: 36.42 0 0.00% 19:30 10/23 EDT
OPEN
36.33
PREV CLOSE
36.34
HIGH
36.42
LOW
36.33
VOLUME
574.32K
TURNOVER
--
52 WEEK HIGH
36.67
52 WEEK LOW
18.80
MARKET CAP
1.45B
P/E (TTM)
104.93
1D
5D
1M
3M
1Y
5Y
1D
Pacira BioSciences Consensus Price Target Increased 17.74% to $35.13
NASDAQ · 1d ago
Weekly Report: what happened at PCRX last week (1012-1016)?
Weekly Report · 5d ago
What Pacira BioSciences Doubters Got Wrong
Simply Wall St · 6d ago
Pacira BioSciences (PCRX), Why Is The Market Paying Closer Attention?
Simply Wall St · 10/16 15:37
Top 3 Health Care Stocks That May Fall Off A Cliff In October
Benzinga · 10/16 12:49
Can Pacira BioSciences (PCRX) Justify Its Buyout Price On Earnings?
Simply Wall St · 10/15 10:31
Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and Pacira Pharmaceuticals (PCRX)
TipRanks · 10/13 12:20
Viatris: Is The Pacira Deal A Game Changer? (Rating Upgrade)
Seeking Alpha · 10/12 16:11
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.